Societal burden and economics of vascular dementia: Preliminary results from a Swedish-population-based study

International Psychogeriatrics

Volumn 15, Issue SUPPL. 1, 2003, Pages 251-256

  Wimo, Anders ^a,b   Winblad, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Box 16 ^*  (Sweden)

Author keywords

Costs; Kungsholmen project; Nordanstig; Resource utilization; RUD; Vascular dementia

Indexed keywords

AGED; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; DEMENTIA; DISEASE SEVERITY; FAMILY; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; POPULATION RESEARCH; RESOURCE ALLOCATION; RURAL POPULATION; SOCIAL SUPPORT; SOCIOECONOMICS; SPOUSE; SWEDEN;

AGED; CANADA; COST OF ILLNESS; DEMENTIA, VASCULAR; DENMARK; ENGLAND; GERMANY; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; ITALY; NETHERLANDS; POPULATION SURVEILLANCE; PSYCHOLOGY; SWEDEN; UNITED STATES;

EID: 0141708010     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610203009281     Document Type: Conference Paper

References (19)

1. Bachynsky, J., McCracken, P., Lier, D., Alloul, K., & Jacobs, P. (2000). Propentofylline treatment for Alzheimer disease and vascular dementia: an economic evaluation based on functional abilities. Alzheimer Disease and Associated Disorders, 14, 102-111.
2. Cavallo, M. C., & Fattore, G. (1997). The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Disease and Associated Disorders, 11, 184-190.
3. Ernst, R. L., & Hay, J. W. (1994). The US economic and social costs of Alzheimer's disease revisited. American Journal of Public Health, 84, 1261-1264.
4. Fratiglioni, L., Forsell, Y., Aguero Torres, H., & Winblad, B. (1994). Severity of dementia and institutionalization in the elderly: Prevalence data from an urban area in Sweden. Neuroepidemiology, 13, 79-88.
5. Fratiglioni, L., Viitanen, M., Backman, L., Sandman, P. O., & Winblad, B. (1992). Occurrence of dementia in advanced age: The study design of the Kungsholmen Project. Neuroepidemiology, 11(Suppl. 1), 29-36.
6. Hay, J.W., Sano, M., & Whitehouse, P. J. (1997). The costs and social burdens of Alzheimer disease: What can and should be done? Alzheimer Disease and Associated Disorders, 11, 181-183.
7. Jonsson, B., Jonsson, L., & Wimo, A. (2000). In M. May & N. Sartorius (Eds.), Dementia. WPA series evidence and experience in psychiatry (pp. 335-363). London: John Wiley & Sons.
8. Koopmanschap, M. A., Polder, J. J., Meerding, W. J., Bonneux, L., & van der Maas, P. J. (1998). In A. Wimo, B. Jonsson, G. Karlsson, & B. Winblad (Eds.), The health economics of dementia. London: John Wiley & Sons.
9. Kronborg Andersen, C., Sogaard, J., Hansen, E., Kragh-Sorensen, A., Hastrup, L., et al. (1999). The cost of dementia in Denmark: The Odense Study. Dementia and Geriatric Cognitive Disorders, 10, 295-304.
10. Ostbye, T., & Crosse, E. (1994). Net economic costs of dementia in Canada. Canadian Medical Association Journal, 151, 1457-1464.
11. Rockwood, K., Brown, M., Merry, H., Sketris, I., & Fisk, J. (2002). Societal costs of vascular cognitive impairment in older adults. Stroke, 33, 1605-1609.
12. Schulenberg, J., & Schulenberg, I. (1998). In A. Wimo, B. Jonsson, G. Karlsson, & B. Winblad (Eds.), The health economics of dementia. London: John Wiley & Sons.
13. Smith, K. A., & Shah, A. (1995). The prevalence and costs of psychiatric disorders and learning disabilities. British Journal of Psychiatry, 166, 9-18.
14. Wimo, A., Johansson, L., von Strauss, E., & Nordberg, G. (1999). Formal and informal home care to Swedish demented patients, an application of RUD (Resource Utilization in Dementia) (Abstract). International Psychogeriatrics, 11(Suppl. 1), 197.
15. Wimo, A., & Jonsson, L. (2001). Social-styrelsen (The National Board of Wealth and Health Care). Stockholm, Sweden.
16. Wimo, A., Karlsson, G., Sandman, P. O., Corder, L., & Winblad, B. (1997). Cost of illness due to dementia in Sweden. International Journal of Geriatric Psychiatry, 12, 857-861.
17. Wimo, A., Wetterholm, A. L., Mastey, V., & Winblad, B. (1998a). In A. Wimo, B. Jonsson, G. Karlsson, & B. Winblad (Eds.), The health economics of dementia. London: John Wiley & Sons.
18. Wimo, A., Witthaus, E., Rother, M., & Winblad, B. (1998b). Economic impact of introducing propentofylline for the treatment of dementia in Sweden. Clinical Therapeutics, 20, 552-566; discussion 550-551.
19. Winblad, B., Hill, S., Beermann, B., Post, S. G., & Wimo, A. (1997). Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Disease and Associated Disorders, 11, 39-45.